Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FlyteHealth vs Oxford's Medical Weight Loss (The Calibrate Clinic)

FlyteHealth
Graded #363

Higher grade

vs+3.6000000000000014

The verdict

FlyteHealth takes it — 58.6/100 to 55/100.

FlyteHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FlyteHealth is an obesity-medicine telehealth platform distributed mainly through employers, payers, and health plans, with care led by board-certified obesity-medicine physicians plus nurse practitioners,…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationEven
40
40
Clinical oversightFlyteHealth +11
83
72
Labs & monitoringFlyteHealth +12
73
61
FulfillmentOxford's Medical Weight Loss (The Calibrate Clinic) +3
62
65
Contract termsEven
55
55
FlyteHealth · left barOxford's Medical Weight Loss (The Calibrate Clinic) · right bar

The numbers

MetricFlyteHealthOxford's Medical Weight Loss (The Calibrate Clinic)
WeighScore58.6/10055/100
GradeCC
Scorecard rank#363#450
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
FlyteHealth

Graded #363 · C

Strengths

  • Care led by board-certified obesity-medicine physicians
  • Multidisciplinary team with NPs, dietitians, and care coordinators
  • Published outcomes of about 13 to 16 percent weight loss over 12 months
  • High GLP-1 medication adherence (around 86 percent in reported data)
  • Comprehensive cardiometabolic care beyond GLP-1 alone

Where it loses points

  • Distributed primarily via employers, payers, and health plans, not direct cash-pay
  • Access is largely gated behind employer or plan sponsorship
  • GLP-1 is prescribed only when appropriate, not guaranteed
  • Self-pay pricing is not publicly listed (contact required)
  • Less suited to consumers wanting fast direct-to-door GLP-1

Strengths

  • Both semaglutide and tirzepatide available
  • No monthly doctor fees and free, no-obligation consultation; free shipping to your door

Where it loses points

  • Only a '$149 starting' figure is advertised (drug/dose unspecified); full GLP-1 pricing stays quote-gated

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard